Masters of Pediatric Dermatology Symposium Poster Presentation: First in Human Phase 2 Trial of Zabalafin (AB-101) – Interim Results

Alphyn Logo 1

NEWS PROVIDED BY
Alphyn Biologics
February 8, 2023, 17:00 ET

CONTACTS

 

Corporate:
Neal Koller
[email protected]
(410) 690-8687

 

Media:
Susan Thomas
[email protected]
(619) 540-9195